You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The integration on the Microsoft Azure cloud is helping Kaiser make its vast genomics dataset available to a wider pool of researchers.
Up to 35 private and public labs in France will be able to use UgenTec's FastFinder analysis software to scale up testing for SARS-CoV-2 and other pathogens.
Belgium's OncoDNA believes that IntegraGen's bioinformatics platform will help it manage more cancer patient data and quickly generate patient-specific treatment reports for clinicians.
Formerly the data analytics division of CTCA, Vidence is supporting an immuno-oncology trial for BMS as it looks to grow its network of hospital partners.
The company hopes to improve its Dragen analysis platform with data compression technology from Enancio and data management capabilities from BlueBee.
Facing questions over data security in the US and Ireland, the company has changed its name as it looks to shed its China operations.
The deal expands Illumina's cloud-based data analysis portfolio and gives its customers access to tools to boost assay and operational efficiency.
Fresh off a new investment round, the British firm seeks to help research labs and biopharma companies manage population-level genomics research.
The funding will support the firm's international market expansion on the heels of the release of Lifebit CloudOS version 2.0 this week.
The French bioinformatics and genomic services company will help Dana-Farber manage clinical research data for the cancer center's new interpretive genomics program.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.